Safety and Efficacy of Tofacitinib in Patients with Active Psoriatic Arthritis: Interim Analysis of OPAL Balance, an Open-Label, Long-Term Extension Study
Rheumatol Ther 2020 doi.org/10.1007/s40744-020-00209-4
View and download slide summaries of the latest original articles focusing on therapies in immune-mediated inflammatory diseases including rheumatology, dermatology, and gastroenterology. All materials produced by the team are subsequently reviewed and approved by individual Steering Committee members.
Rheumatol Ther 2020 doi.org/10.1007/s40744-020-00209-4
Arthritis Res Ther 2020;22:142
RMD Open 2020;6:e001174 doi:10.1136/rmdopen-2020-001174
Arth Res Ther 2020;22:115 doi.org/10.1186/s13075-020-02199-8
Clin Exp Rheumatol . Jul-Aug 2020;38(4):732-741. Epub 2020 May 20.
Arthritis Rheumatol. 2020 Sep; 72(9): 1435–1446.
Drug Saf. 2020;43:379-392
Ann Rheum Dis. 2020 10.1136/annrheumdis-2019-216566
Intern Med. 2020;59(6):817-821
Ther Adv Musculoskelet Dis. 2020;12:1759720X19899296